PM360

SEPTEMBER 21, 2023

They do not have biosimilar or generic competition available in the market. The MFPs will be announced publicly in September 2024 and go into effect on January 1, 2026. Additionally, highly competitive classes, such as rapid-acting insulin and immunologics are included on the selected drug list.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

European Pharmaceutical Review

SEPTEMBER 14, 2023

Ultimately, this puts European businesses at a competitive disadvantage compared to other companies worldwide. Once adopted by the Council, the regulatory proposals are planned to come into force on 1 July 2028 (for BEFIT) and on 1 January 2026 (for the transfer pricing proposal).

Competition 97

Competition Pharma Pharmaceutical 97

Pharmaceutical Technology

MAY 29, 2023

It provides forward-looking analysis of the market including market sizing up to 2026, segmentation by application, potential growth opportunities, and competitive pr Buy the report here.

Pharmaceutical 52

Pharmaceutical Marketing Competition Medicine 52

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said. Starting in 2026, the provision will affect 10 Part D drugs.

Management 105

Management Manufacturing Sales Competition 105

European Pharmaceutical Review

AUGUST 22, 2022

However, China and India are set to be fierce competition over the next decade, with 30 percent of respondents suggesting they would offshore >50 percent of clinical trials and operations to India, China or other lower-cost countries over the next five years.

Biopharma 98

Biopharma Manufacturing Marketing Competition 98

pharmaphorum

OCTOBER 17, 2022

It remains to be seen whether the data from VALOR will convince the regulator to grant conditional approval while it waits for results from a confirmatory phase 3 trial (ATLAS ) in SOD1-ALS, which is due to generate results in 2026.

FDA 52

FDA Prospecting Competition Safety 52

Clarivate

AUGUST 27, 2024

FDA approval in the fourth quarter, with Johnson & Johnson’s Varipulse system close behind, so competition will pick up. Abbott’s Volt should join the party in early 2026. Still, analysts and providers project that Farapulse, which has more than 70% of the global market today, will continue to dominate at least through 2025.

Marketing 52

Marketing Competition FDA Electronics 52

Clarivate

OCTOBER 25, 2023

The initial list, which takes effect in 2026, has the potential to roil formularies since it includes a mix of high-volume, preferred brands and a group of high-cost specialty drugs for autoimmune conditions (psoriasis) and cancer. exclusions exist for orphan drug designation and biosimilar competition ).

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Clarivate

AUGUST 7, 2024

These moves mark a strategic shift towards greater transparency and predictability, driven by regulatory pressures and rising competition from market disruptors. Express Scripts added ClearNetwork in late 2023, while CVS Caremark introduced CostVantage and TrueCost in early 2024, mirroring the strategies of ESI and OptumRx.

Retail 59

Retail Marketing Competition Biopharma 59

Clarivate

MAY 14, 2024

Competition is expected to intensify in the next few years as both Novo Nordisk and Eli Lilly plan to launch their respective weight-loss drugs in Mainland China. Robust clinical data around multiple cardiometabolic indicators supported by all three assets is poised to lead widespread adoption in Mainland China.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

PM360

APRIL 7, 2023

However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. Expect the nine competitors to explore Kotler’s 4Ps of Marketing to gain share in this lucrative and competitive marketplace.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

pharmaphorum

JANUARY 10, 2023

billion by 2026, according to research by the Business Research Company. If you have to wait to extract meaning from your data then you won’t be competitive enough. “A I believe huge opportunities await organisations that properly leverage their data.”. billion in 2021 to $9.23 About half raised their hands.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

PM360

FEBRUARY 1, 2024

Those numbers are predicted to increase to 84% and 93%, respectively, by 2026 while the total annual spend for these trials across all phases is expected to increase significantly in the next few years.

Recruitment 52

Recruitment Healthcare Healthcare Management 52

Pharmaceutical Technology

JANUARY 10, 2023

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).

Marketing 52

Marketing Physicians Leads Sales 52

Spotio

APRIL 21, 2023

Recent research shows that the hardware as a service market (HaaS) should reach $300+ billion in 2026. While the demand is high, the competition is fierce. Do you sell POS systems? Then you have a lot to look forward to. Other studies predict the POS space, specifically, to grow by 6.9% To give yourself an edge, invest in SPOTIO.

Sales 52

Sales Prospecting Leads Sales pitches 52

Spotio

JUNE 6, 2022

For example : SPOTIO’s Lead Machine gives reps and managers a competitive advantage because they are able to quickly build detailed customer profiles and map territories filled with qualified prospects in minutes. With so much potential, comes a lot of competition. The average person receives 147 emails every day!

Sales 111

Sales Prospecting B2B Sales Leads 111

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. She holds a degree in Neuroscience from the University of Nottingham.

Doctors 59

Doctors Medicine Marketing Sales 59

Clarivate

APRIL 24, 2023

Oak Street has 169 locations across 21 states and expects to nearly double its size to 300 centers by 2026. billion deal to acquire Oak Street Health, a value-based primary-care company focused on treating Medicare patients. In January 2023, VillageMD acquired Summit Health for $8.9

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

European Pharmaceutical Review

FEBRUARY 7, 2023

However, a delicate balance will need to be struck between the need for affordable and accessible medicinal products and the desire to foster innovation and competitiveness in the EU. of the MDR and Article 110.4 of the IVDR for medical devices and in vitro diagnostic medical devices (IVDs).

Medical 117

Medical Government Marketing Medicine 117

PM360

SEPTEMBER 28, 2022

Maximum Fair Prices published: The first round of negotiated Maximum Fair Prices will be published in August 2024, scheduled to take effect in 2026. Plan bids will reflect negotiated prices for the first time in 2025 (for the 2026 plan year), affecting formulary and coverage strategies. Enterprise view of portfolio is critical.

Government 97

Government Manufacturing Prescription Competition 97

Clarivate

APRIL 18, 2024

Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. CVS expects to accelerate Oak Street’s footprint expansion in coming years, with previously stated plans of having more than 300 centers in total by 2026. Source: News reports and company releases.

Retail 52

Retail Healthcare Healthcare Physicians 52

Clarify Health

FEBRUARY 6, 2024

That way, they can continue to grow membership and thrive against the competition. In 2026, payers will need to send prior authorization decisions within 72 hours for urgent requests and seven business days for standard requests. These changes are designed to make care easier to access for enrollees.

Networking 52

Networking Insurance Government Management 52

Evolve Your Success

JANUARY 24, 2023

If it’s 2026 and you’re reading this, this happened in 2023. This determination led me to an incredibly fulfilling career as an OB registered nurse and opened the door to my ultimate dream of transferring my patient-centered skills to a career in medical sales where my charisma, drive, and competitive nature can fully thrive.

Medical sales 52

Medical sales Sales Medical Education 52

Pharmaceutical Technology

MAY 25, 2023

Analysis estimates that the oncolytic virus market will reach $1 billion by 2026. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Safety 52

Safety Patients Prospecting Marketing 52

Clarivate

AUGUST 20, 2024

Price negotiations will be staggered over time, beginning with this initial list of ten Part D drugs that takes effect in 2026 (Part D is the prescription drug coverage component of Medicare, a federal health insurance program for people 65 and older which covers nearly 1 in 5 Americans). These ten drugs cost Medicare Part D nearly $46.8

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

Clarivate

OCTOBER 17, 2024

As California Attorney General from 2011 to 2017, Harris was a forceful opponent of healthcare industry consolidation, both vertical and horizontal, believing that mergers of hospitals, physician groups and insurers would damage competition and raise prices for care. 31, 2024, and providers and payers are pushing for an extension.

Healthcare 52

Healthcare Healthcare Government Insurance 52